Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results for the Quarter ended September 2026

To, To, The Department of Corporate Services Listing Department BSE Limited National Stock Exchange of India Ground Floor, P. J. Tower, Limited Dalal Street, Exchange Plaza, 5" Floor Plot No. C/1, Mumbai-400001 G. Block Bandra-Kurla Complex, Secrip Code: 524632 Bandra (E), Mumbai - 400 051 NSE Symbol: SHUKRAPHAR Dear Sir/Madam, Sub: Intimation of Board Meeting pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 29 read with other applicable Regulation of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 3" November, 2026 at the Registered Office of the Company inter alia to consider and approve the following: - 1. Unaudited financial result for the second quarter and half year ended on 30" September, 2026 along with the Auditor's Limited Review Report. 2. Any other business with the permission of Chairman. Please take the same on your record and oblige. Thanking you, Yours faithfully, For Shukra Medtech Limited (Formerly known as Shukra Pharmaceuticals Limited) Plofed Shivkant Dhakad Company Secretary Membership Number: A80894 CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhin- a38g27a21r, Gujarat, India, Ph. : 02764-286317